Ads
related to: vtgn stock- thinkorswim®
Access The Award-Winning Platform
Built By Traders, For Traders.
- Pricing for Online Trades
No Account Fees or Platform Fees
With Schwab's Trading Services.
- thinkorswim® Guest Pass
Try A Demo For 30 Days For Free.
No Account Required With Guest Pass
- Trader Education
Explore Our Education Library To
Get From "How?" to "Know-How."
- Start Trading Today
Open Your Brokerage Account With
Schwab For No Trade Minimums.
- Trading At Schwab
Now Powered By Ameritrade.
Learn More.
- thinkorswim®
Search results
What Makes VistaGen Therapeutics, Inc. (VTGN) a New Buy Stock
Zacks via Yahoo Finance· 1 year agoVistaGen Therapeutics, Inc. (VTGN) might move higher on growing optimism about its earnings...
How Vistagen (VTGN) Stock Stands Out in a Strong Industry
Zacks via Yahoo Finance· 4 months agoOne stock that might be an intriguing choice for investors right now is Vistagen Therapeutics, Inc....
Insiders who bought stock earlier this year lose -US$12k as VistaGen Therapeutics, Inc....
Simply Wall St. via Yahoo Finance· 2 years agoThe recent price decline of 15% in VistaGen Therapeutics, Inc.'s (NASDAQ:VTGN) stock may have...
Retail investors are Vistagen Therapeutics, Inc.'s (NASDAQ:VTGN) biggest owners and were rewarded...
Simply Wall St. via Yahoo Finance· 5 months agoKey Insights Significant control over Vistagen Therapeutics by retail investors implies that the...
VistaGen Therapeutics, Inc. (VTGN) Reports Q2 Loss, Misses Revenue Estimates
Zacks via Yahoo Finance· 1 year agoVistaGen Therapeutics, Inc. (VTGN) delivered earnings and revenue surprises of 0% and 388.07%,...
7 Cheap Biotech Stocks to Buy Now
InvestorPlace via Yahoo Finance· 2 years agoThis article covers seven cheap biotech stocks for investors with a high risk tolerance. ImmunityBio (IBRX): Boasts an extensive pipeline that covers...
Shareholders Will Likely Find VistaGen Therapeutics, Inc.'s (NASDAQ:VTGN) CEO Compensation...
Simply Wall St. via Yahoo Finance· 1 year agoThe performance at VistaGen Therapeutics, Inc. (NASDAQ:VTGN) has been rather lacklustre of late and...
Vistagen Strengthens Its Neurology Focused Pipeline With Pherin Pharma Acquisition
Benzinga via Yahoo Finance· 1 year agoVistagen Therapeutics Inc (NASDAQ: VTGN) has agreed to acquire Pherin Pharmaceuticals Inc in an...
VistaGen Therapeutics, Inc. (NASDAQ:VTGN) Q3 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 2 months agoVistaGen Therapeutics, Inc. (NASDAQ:VTGN) Q3 2024 Earnings Call Transcript February 13, 2024...
2 “Strong Buy” Penny Stocks That Could Go Boom
TipRanks via Yahoo Finance· 2 years agoBetween the Fed's aggressive policy tightening to rein in inflation and deteriorating economic data, volatility has become a seemingly ever-present facet...
